Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo (Q41741739)

8 October 2017

Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo (English)

1 reference

8 October 2017

0 references

Tu G

1

1 reference

8 October 2017

Kirchmaier AL

2

1 reference

8 October 2017

Liggitt D

3

1 reference

8 October 2017

Liu Y

4

1 reference

8 October 2017

Liu S

5

1 reference

8 October 2017

Yu WH

6

1 reference

8 October 2017

Heath TD

7

1 reference

8 October 2017

Thor A

8

1 reference

8 October 2017

Debs RJ

9

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

Journal of Biological Chemistry

8 October 2017

1 reference

8 October 2017

275

1 reference

8 October 2017

39

1 reference

8 October 2017

30408-30416

1 reference

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

8 October 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Systemic gene therapy: biodistribution and long-term expression of a transgene in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Safety-modified episomal vectors for human gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4− CD8+ cytotoxic T lymphocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Isolation of human sequences that replicate autonomously in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Prolonged transgene expression in rodent lung cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Endothelial cell proliferation as a novel approach to targeting tumour therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

An improved plasmid DNA expression vector for direct injection into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Cationic liposome-mediated intravenous gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Selective extraction of polyoma DNA from infected mouse cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Improved DNA: liposome complexes for increased systemic delivery and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

A second dose of a CFTR cDNA-liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Pathology and immunogenicity in the cotton rat (Sigmodon hispidus) model after infection with a bovine adenovirus type 3 recombinant virus expressing the firefly luciferase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Long-term replication of Epstein-Barr virus-derived episomal vectors in the rodent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Prolonged expression of therapeutic levels of human granulocyte colony-stimulating factor in rats following gene transfer to skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Systemic gene delivery expands the repertoire of effective antiangiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

Epstein-Barr virus-based vectors that replicate in rodent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004782200

21 January 2018

Identifiers

DOI

10.1074/JBC.M004782200

1 reference

8 October 2017

1 reference